Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cemtrex (CETX) Asset Writedowns and Impairment: 2017-2025

Historic Asset Writedowns and Impairment for Cemtrex (CETX) over the last 5 years, with Jun 2025 value amounting to $44,650.

  • Cemtrex's Asset Writedowns and Impairment fell 96.80% to $44,650 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.5 million, marking a year-over-year decrease of 202.69%. This contributed to the annual value of -$79,006 for FY2024, which is 444.31% down from last year.
  • Cemtrex's Asset Writedowns and Impairment amounted to $44,650 in Q2 2025, which was up 148.90% from $17,939 recorded in Q1 2025.
  • In the past 5 years, Cemtrex's Asset Writedowns and Impairment ranged from a high of $1.4 million in Q2 2024 and a low of -$1.5 million during Q3 2024.
  • Its 3-year average for Asset Writedowns and Impairment is -$4,281, with a median of $6,676 in 2023.
  • Examining YoY changes over the last 5 years, Cemtrex's Asset Writedowns and Impairment showed a top increase of 100,373.92% in 2024 and a maximum decrease of 10,406.94% in 2024.
  • Over the past 5 years, Cemtrex's Asset Writedowns and Impairment (Quarterly) stood at $94,588 in 2021, then crashed by 95.23% to $4,510 in 2022, then surged by 165.28% to $11,964 in 2023, then crashed by 161.58% to -$7,367 in 2024, then crashed by 96.80% to $44,650 in 2025.
  • Its Asset Writedowns and Impairment was $44,650 in Q2 2025, compared to $17,939 in Q1 2025 and -$7,367 in Q4 2024.